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Sphingolipids are typically formed by the condensation 
of  serine and palmitoyl-CoA, a  reaction catalyzed by  the 
serine-palmitoyltransferase  (SPT)  enzyme.  Besides  these 
canonical substrates, SPT can use other acyl-CoAs, but also 
alanine or glycine, as substrates, which then form a cate-
gory of atypical 1-deoxysphingolipids (1-deoxySLs) that 
lack the C1-OH group of canonical sphingolipids (1, 2).
Several missense mutations in SPT, which are associated 
with the rare inherited neuropathy, HSAN1, induce a per-
manent shift in the substrate specificity of the enzyme re-
sulting in increased 1-deoxySL formation. HSAN1 is a rare 
autosomal and dominantly inherited axonopathy and is 
clinically  characterized by a progressive  loss of pain and 
Abstract The 1-deoxysphingolipids (1-deoxySLs) are 
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ine-palmitoyltransferase, and are devoid of the C1-OH-
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elevated 1-deoxySL levels are associated with the rare inher-
ited neuropathy, HSAN1, and diabetes type 2 and might 
contribute to  cell failure and the diabetic sensory neu-
ropathy. In analogy to canonical sphingolipids, it was as-
sumed that 1-deoxySLs also bear a (4E) double bond, which 
is normally introduced by sphingolipid delta(4)-desaturase 1. 
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oxysphinganine and compared the downstream formed 
D3-1-deoxysphingosine (1-deoxySO) to a commercial syn-
thetic SPH m18:1(4E)(3OH) standard. Both compounds 
showed the same m/z, but differed in their RPLC reten-
tion time and atmospheric pressure chemical ionization 
in-source fragmentation, suggesting that the two compounds 
are structural isomers. Using dimethyl disulfide derivatiza-
tion followed by MS2 as well as differential-mobility spec-
trometry combined with ozone-induced dissociation MS, 
we identified the carbon-carbon double bond in native 
1-deoxySO to be located at the (14) position. Comparing 
the chromatographic behavior of native 1-deoxySO to chemi-
cally synthesized SPH m18:1(14Z) and (14E) stereoisomers 
assigned the native compound to be SPH m18:1(14Z).  
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and the lower (organic) phase washed three times with alkaline 
water. The organic phase was finally dried under N2 and stored at 
20°C until analysis.
Throughout this work, we refer to the extracted 1-deoxySO as 
native.
LC-MS method
A  commercial  1-deoxySO  standard  [SPH m18:1(4E)(3OH)] 
was purchased from Avanti Polar Lipids. SPH m18:1(14Z)(3OH) 
was synthesized according to the method described below. The 
SPH m18:1(E)(3OH) standards (5E, 8E, 12E, 13E, and 14E) were 
synthesized based on an unpublished method that will be issued 
elsewhere. An LC-MS method described previously (8) was used 
to compare retention times and in-source fragmentation. Sphin-
goid bases were separated by RPLC on a C18-column (Uptisphere 
120 Å, 5 m, 125 × 2 mm; Interchim, Montluçon, France) and 
analyzed on  a TSQ Quantum Ultra  or  a Q Exactive  (Thermo, 
Reinach BL, Switzerland) using an atmospheric pressure chemi-
cal ionization (APCI) interface. Mobile phases consisted of ultra-
pure water/methanol (1/1 v/v) with 2.6 mM ammonium acetate 
(mobile phase A) and methanol (mobile phase B). Gradient was 
set from 50% B to 100% B within 25 min followed by 5 min 100% 
B and 5 min of equilibration with a flow rate of 0.3 ml/min. For 
mass spectral detection, the following parameters were set on the 
APCI source: discharge current of 4 A, vaporizer temperature 
of 450°C, sheath gas pressure of 20 AU, auxiliary gas pressure of 
5 AU, and capillary temperature of 200°C.
Dimethyl disulfide adduct analysis
Dimethyl disulfide (DMDS, 100 l) and 20 l of I2 (in diethyl 
ether, 60 mg/ml) were added to whole cell extracts or 15 nmol 
SPH m18:1(4E)(3OH) standard. Samples were agitated for 16 h 
in an Eppendorf Thermo shaker at 1,400 rpm and 35°C. The re-
action was quenched with 100 l of 5% aqueous Na2S2O3, ex-
tracted with 200 l of hexane, and dried under N2. Samples were 
dissolved in 200 l isopropanol for further analysis according to 
the method of Dunkelblum, Tan, and Silk (9). The sample was 
directly injected into the mass spectrometer at a flowrate of 
10 l/min. The [M+H]+ ion of the DMDS adduct of 1-deoxySO 
was generated by ESI on a Thermo Fisher Scientific Q-Exactive 
and both collision-induced dissociation (CID) and high-resolution 
accurate mass analysis were performed. For detection, the follow-
ing parameters were set on the ESI source: spray voltage of 
4.2 kV, vaporizer temperature of 30°C, sheath gas pressure of 5 AU, 
auxiliary gas pressure 0 AU, capillary temperature of 320°C, and, 
for  fragmentation,  in-source CID was  performed  at  30  eV  and 
higher-energy CID of the ion at m/z 378.3 was performed with a 
setting of 25.
Differential-mobility spectrometry combined with ozone-
induced dissociation
A SelexIONTM differential-mobility spectrometer was employed 
with a QTRAP®5500 triple quadrupole ion-trap mass spectrome-
ter (SCIEX, Ontario, Canada). The instrument was modified for 
ozone-induced dissociation (OzID) as previously described (10). 
Solutions for analysis were prepared in LC-grade methanol (VWR 
Scientific, Murrarie, QLD, Australia) with 5 mM UPLC-grade am-
monium acetate  (Sigma-Aldrich,  St. Louis, MO); SPH  standard 
concentrations were 0.05 M. Sample solutions were subjected 
to ESI in a TurboVTM (SCIEX) and passed through the mobil-
ity spectrometer. Compensation voltage (CV) applied across the 
electrodes was scanned while the separation voltage was held con-
stant at 4,100 V. Ionograms were obtained from scanning CV and 
represent the sum of five mass spectra at each voltage point and 
have been smoothed using PeakView® (SCIEX). The ESI source 
temperature sensation, often accompanied by neuropathic 
pain attacks and skin ulcers (3). The 1-deoxySLs are toxic 
to primary sensory neurons in culture and lead to neurite 
retraction and the disruption of the neuronal cytoskeleton 
structure  in  a dose-dependent manner  (3,  4). They  also 
interfere with the survival and insulin secretory capacity of 
pancreatic  cells and 1-deoxySL plasma levels have been 
found to be prospective biomarkers for the risk to develop 
diabetes type 2 (5–7).
The 1-deoxysphinganine (1-deoxySA), which is formed 
by SPT, can be converted to 1-deoxyceramides, but not 
to complex sphingolipids, because of the missing 1-OH 
group. During catabolism, 1-deoxyceramide is degraded by 
ceramidase to form 1-deoxysphingosine (1-deoxySO), but 
is not phosphorylated to form the catabolic intermediate, 
sphingosine-1-phosphate (S1P). This prevents its cleavage 
to hexadecenal by S1P-lyase, meaning that 1-deoxySLs can-
not be degraded by the canonical catabolic pathway (2). 
Apart from that, it was assumed that 1-deoxySA is me-
tabolized by the same set of enzymes as canonical sphin-
goid bases and that 1-deoxySO, like sphingosine, bears a 
(4E) double bond that is introduced by the sphingolipid, 
delta(4)-desaturase 1.
However, we observed that natively formed 1-deoxySO 
showed a different RPLC retention time than a synthetic 
SPH  m18:1(4E)(3OH) standard, though the m/z was 
identical for both compounds. This suggested that native 
1-deoxySO  and  the  synthetic  SPH m18:1(4E)(3OH) are 
structural isomers, probably differing in position and/or 
configuration of the carbon-carbon double bond. To fur-
ther elucidate this difference, we used a set of tandem MS 
methods in combination with total synthesis to elucidate 
the real double bond position and configuration of native 
1-deoxySO.
MATERIALS AND METHODS
Unless stated differently, all solvents and reagents were pur-
chased from Sigma-Aldrich Chemie GmbH (Buchs, Switzerland) 
excluding methanol, which was purchased from Honeywell Spe-
cialty Chemicals Seelze GmBH, Germany.
Cell extract
HEK293 cells were fed with 1 M deuterium-labeled D3-1- 
deoxySA (Avanti Polar Lipids, Alabaster, AL) or with the unlabeled 
1-deoxySA (Avanti Polar Lipids). Cells were harvested after 24 h 
and the whole sphingolipid extract was hydrolyzed to get the free 
sphingoid bases, as described previously with some modifications 
(7, 8). The cell pellet was dissolved in 100 l of PBS. Methanol 
(500 l), including D7-sphingosine and D7-sphinganine (Avanti 
Polar Lipids) as the internal standards, was added. Lipids were 
extracted for 1 h under constant agitation at 37°C. Samples were 
centrifuged to pellet precipitated proteins and the supernatant 
was transferred into a new tube. Lipids were hydrolyzed by add-
ing 75 l of methanolic HCl (1 N HCl and 10 M water in metha-
nol)  and  incubated  for  16  h  at  65°C.  HCl  was  neutralized  by 
adding 100 l of KOH (10 M). Then, 625 l chloroform was 
added followed by 100 l 2 N ammonium hydroxide and 0.5 ml 
alkaline water to complete phase separation. The sample was vor-
texed, centrifuged at 16,000 g for 5 min, the upper phase discarded 
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Comparison of synthetic SPH m18:1(4E) and native 
1-deoxySO
Retention time and APCI in-source fragmentation was 
compared between native 1-deoxySO and a commercially 
available  synthetic  SPH m18:1(4E)(3OH) standard. The 
native 1-deoxySO eluted from the C18 column after 12.7 
min; whereas, the synthetic SPH m18:1(4E)(3OH) eluted 
after  14.77 min  (Fig.  1A).  The  [M+H]+ ions formed by 
APCI  showed  in-source  fragmentation  and  a  significant 
water loss for the SPH m18:1(4E)(3OH) standard, which 
was considerably less pronounced for the native 1-de-
oxySO (Fig. 1B). As both molecules showed identical m/z 
using high-resolution accurate MS (<2 ppm for [M+H]+ 
and [M+H-H2O]
+), the observed deviations in retention 
time and in-source fragmentation suggested that native 
1-deoxySO and the synthetic SPH m18:1(4E)(3OH) were 
structural isomers.
DMDS derivatization
As the synthetic SPH m18:1(4E)(3OH) and the native 
1-deoxySO showed different RPLC properties, we aimed 
to elucidate the carbon-carbon double bond position of 
native 1-deoxySO by derivatization with DMDS. The DMDS 
adducts of 1-deoxySO were analyzed by high-resolution ac-
curate MS using direct injection and ESI. The [M+H]+ 
ions from the DMDS adducts of 1-deoxySO were selected 
at m/z  378.3  and  subjected  to  CID.  The  CID  spectrum 
showed  four  abundant,  but nonspecific,  product  ions  at 
m/z 330.3 [M+H-CH3SH]
+, m/z 312.3 [M+H-CH3SH-H2O]
+, 
m/z 282.3 [M+H-2CH3SH]
+, and m/z 264.3 [M+H-2CH3SH-
2H2O]
+ corresponding to the neutral loss of methane 
thiols and water as indicated (Fig. 2).
Importantly, two less abundant, but structurally diag-
nostic, product ions were observed at m/z 274.2 (A) and 
m/z 103.1 (B). These product ions were formed by a 
cleavage of the carbon-carbon bond between the two 
methyl sulfide moieties. The mass distribution of the two 
fragments indicated a double bond in (14)-position 
for native 1-deoxySO. Product ions indicating a frag-
mentation at the (4)-position (m/z 243.2 and 134.1) were 
not detected.
Differential-mobility spectrometry combined with OzID
DMS  has  previously  been  deployed  successfully  for 
lipid isomer separation prior to mass spectrometric analy-
sis (10, 13). Here  it was combined with OzID, which ex-
ploits the reaction between mass-selected lipid ions and 
gaseous ozone inside a mass spectrometer to drive frag-
mentation diagnostic of the position(s) of carbon-carbon 
double bonds (12, 14). In these experiments, the D3-labeled 
hydrolyzed extract  from HEK cells was  spiked with a 1:1 
mixture  of  the  unlabeled  commercial  SPH m18:1(4E)
(3OH) and synthesized SPH m18:1(14E)(3OH) structural 
isomers and the mixture subjected to ESI. Figure 3A shows 
DMDS ionograms obtained for m/z 284 (black trace) and 
m/z 287 (red trace) corresponding in mass to the [M+H]+ 
ions expected from unlabeled and labeled 1-deoxySO, re-
spectively. The black trace shows peaks corresponding to 
at least two chemically distinction populations of m/z 284 
and differential-mobility spectrometer cell temperatures were 100 
and 150°C, respectively; the ESI voltage was set to 5,500 V. Nitro-
gen was set to 20 psi for each of the following: resolving gas in the 
differential-mobility  spectrometer  cell,  the  nebulizing  ESI  gas, 
and the MS curtain gas. Ions exiting the differential-mobility 
spectrometer cell into the mass spectrometer were mass selected 
in first quadrupole prior to isolation in the collision cell with 
ozone present. Ozone was produced by an external generator 
(Titan; Absolute Ozone, Alberta, Canada) operating at 220 g/Nm3 
(10.3% v/v ozone  in oxygen) from which a small portion was 
mixed into the nitrogen collision gas input to the mass spectrom-
eter through a variable leak valve (Nenion, Lustenau, Austria). 
The isolation time for ionized lipids in the collision cell was opti-
mized between 100 ms and 15 s depending on the ozone-reactivity 
of a given ionized lipid (11, 12). Following ozonolysis, ions were 
transferred to the third quadrupole region where mass analysis 
was performed using a trap-scan at 1,000 Th/s. OzID spectra ob-
tained at discrete CV values were averaged between 2 and 5 min.
Synthesis of 1-deoxySO [SPH m18:1(14Z)(3OH) or 
(2S,3R,14Z)-2-aminooctadec-14-en-3-ol]
Eleven intermediate compounds en route to the target SPH 
m18:1 (14Z)(3OH) were synthesized as described in the supple-
mentary information. A stirred solution of compound 11 (57 mg, 
3 mmol) in 1,4-dioxane (1 ml) at 0°C was treated with a solution 
of 4 M HCl-dioxane (2 ml) over a period of 10 min. The resulting 
reaction mixture was allowed to stir for 1 h at the same condi-
tions, gradually warmed to ambient temperature, and followed 
by TLC analysis. After being stirred for an additional 2 h [as moni-
tored by TLC, petroleum ether/EtOAc 4:1; Rf(adduct) = 0.5; Rf(product) = 
0.0; visualized with KMnO4 solution], the reaction mixture was 
concentrated under reduced pressure. The resultant residue was 
dissolved in CH2Cl2 (50 ml) and sequentially washed with satu-
rated NaHCO3 solution (40 ml), water (30 ml), and brine solu-
tion  (40  ml).  The  organic  layer  was  subsequently  dried  over 
anhydrous Na2SO4, filtered, and concentrated in vacuo to afford 
a pale yellow oily residue. Flash column chromatography of the 
obtained crude amine over silica gel using ethyl acetate and iso-
propanol as eluents (from 0 to 10% isopropanol in ethyl acetate) 
provided  the  final  compound 12 as colorless oil. Yield: 32 mg 
(71%). Rf:  0.32  (EtOAc/isopropanol  4:1,  visualized  with  1.3% 
ninhydrin). 1H NMR (500 MHz, MeOD)  5.35 (ddd, J = 5.9, 3.6, 
2.8 Hz, 2H), 3.70 (ddd, J = 8.1, 5.3, 3.0 Hz, 1H), 3.26 (qd, J = 6.7, 
3.1 Hz, 1H), 2.07 – 1.98 (m, 4H), 1.52 (dt, J = 10.3, 8.2 Hz, 1H), 
1.47 – 1.41 (m, 2H), 1.41 – 1.28 (m, 18H), 1.21 (d,  J = 6.8 Hz, 
3H), 0.91 (t, J  =  7.4  Hz,  3H).13C  NMR  (126  MHz,  MeOD)   
131.05,  130.65,  71.71,  52.61,  34.02,  30.86,  30.75,  30.73,  30.69, 
30.65, 30.35, 30.31, 28.15, 27.00, 23.98, 14.16, 12.08. high-resolu-
tion MS (ESI+) m/z calculated for C18H38NO [M+H]
+ 284.2953; 
found 284.2959.
RESULTS
1-deoxySO is a downstream metabolite of 1-deoxySA
HEK293 cells were cultured in the presence of deute-
rium-labeled D3-1-deoxySA or unlabeled 1-deoxySA. Cells 
were harvested after 24 h and the profile of the extracted 
sphingoid bases analyzed by RPLC-MS. We observed  the 
appearance of [M+H]+ ions with m/z  284.3  (unlabeled 
1-deoxySO) and of m/z  287.3  (labeled  D3-1-deoxySO), 
which both eluted at the same time from the LC column 
(Fig. 1A), indicating that 1-deoxySO is a product formed 
downstream of 1-deoxySA (labeled and unlabeled).
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Fig. 1.  A: Difference  in RPLC retention time of synthetic SPH m18:1(4E)(3OH) and native 1-deoxySO extracted from HEK293 cells 
treated with 1-deoxySA or D3-1-deoxySA. B: APCI in-source fragmentation of a synthetic SPH m18:1(4E)(3OH) standard, native 1-deoxySO, 
and D3-1-deoxySO: the precursor [M+H]
+ ion (m/z 284) is identical for SPH m18:1(4E)(3OH) and native 1-deoxySO. However, synthetic 
SPH m18:1(4E)(3OH) formed an abundant [M+H-H2O]
+ product ion (m/z 266), which was formed much less from native 1-deoxySO and 
D3-1-deoxySO at identical conditions. MS spectra were recorded on a triple quadrupole MS (TSQ Quantum Ultra) with APCI ionization.
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Fig. 2.  A: Hydrolyzed lipid extract from HEK293 cells was subjected to DMDS derivatization and analyzed 
on a high-resolution accurate mass spectrometer using ESI and direct injection. The [M+H]+ ion formed 
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Elucidating the chemical structure of native 1-deoxySO 1199
8E, 12E, 13E, 14E, and 14Z) were synthesized. Here we focus 
on the synthesis of the SPH m18:1(14Z)(3OH), as details 
on the synthesis of the other derivatives will be published 
elsewhere.  The  synthesis  of  SPH  m18:1(14Z)(3OH) 12 
commenced from commercially available 1,10-decanediol 
(Scheme 1). Treatment of 1,10-decanediol with dihydro-
pyran in the presence of a catalytic amount of p-toluene-
sulfonic acid afforded the mono-THP ether 3 in moderate 
yield. Subsequent conversion of mono-hydroxyl compound 
3 to the corresponding bromo derivative 4 was accom-
plished through treatment of 3 with tetrabromomethane 
(CBr4) and triphenyl phosphine (PPh3) to provide com-
pound 4. With intermediate 4 in hand, the coupling with 
lithiated 1-pentyne was performed following a previously 
described protocol (16) with some modifications (see sup-
plementary Table 1 for details). Thus, tert-butyllithium was 
added to 1-pentyne at 78°C, and the in situ generated 
1-lithio-1-pentyne  was  sequentially  reacted  with  DMPU 
and bromo substrate 4 to afford compound 5 in a satisfac-
tory yield. Subsequent stereoselective hydrogenation of 
alkyne 5 was accomplished with Lindlar catalyst after 
optimization of reaction conditions to afford the desired 
Z-configuration of the alkene 6 as a sole isomer (see sup-
plementary Table 2 for more details). It is noteworthy that 
initial attempts to furnish alkene 6 led to a product that 
was contaminated (10–15%) with inseparable by-products. 
Careful analysis of 1H-NMR spectra of the crude mixture 
identified  these  by-products  as  the  E-configured  alkene 
and the over-reduced product, 1-bromopentadecane. 
Cleavage of the THP-protecting group in 6 under acid-
catalyzed  ethanol  treatment  proceeded  smoothly  to 
provide the hydroxyl alkene 7, which was subsequently 
subjected to Appel reaction with CBr4/PPh3 to furnish the 
Z-bromo-alkene 8.
Next, the obtained bromo-alkenyl chain 8 was converted 
into  the  corresponding  Grignard  reagent  9 and subse-
quently coupled to the Weinreb amide 2 (prepared from 
L-alanine in two steps, see the supplementary information 
for details). Toward this end, Weinreb amide 2 was reacted 
with 0.9 equivalent of methylmagnesium bromide (as sac-
rificial base), followed by addition of the Grignard reagent 
9 to afford ketone 10 in 78% isolated yield. The subsequent 
diastereoselective reduction of the carbonyl group in 10 
with lithium tri-(tert-butoxy)-aluminum hydride (1.7 equiv-
alent) in absolute ethanol at 78°C was accomplished 
without reduction of the double bond to furnish the de-
sired anti-amino alcohol 11 as a mere stereoisomer. Acidic 
hydrolysis of the tert-butyl carbamate protecting group of 
11 with 4 M HCl-dioxane solution yielded the correspond-
ing  hydrochloric  salt  of  SPH m18:1(14Z)(3OH) (.HCl). 
The desired product 12 was finally obtained after neutral-
ization workup in 71% yield.
(i.e., isobars): one with a maximum CV at around 17 V and 
another peaking at 20 V. Isobars carrying m/z 284 in this 
mixture should be dominated by the protonated forms of 
the synthetic SPH m18:1(4E)(3OH) and SPH m18:1(14E)
(3OH) isomers. The red trace, corresponding to isobars of 
m/z 287 (Fig. 3A), showed an analogous pair of peaks at 
CV 17 and 20 V. These signals could be assigned to [M+H]+ 
ions arising from native forms of 1-deoxySO present in the 
cell extract. To interrogate the structure of the ions re-
sponsible for each of the two peaks in the ionogram, OzID 
spectra were acquired for m/z 284 and 287 ions using fixed 
CV settings of 17 and 20 V. Figure 3B shows product ions 
arising from the synthetic lipids (at m/z 284) in black and 
the corresponding D3-labeled native lipid (at m/z 287) in 
red. Both spectra revealed product ions arising from neu-
tral loss of 40 and 24 Da, characteristic of ozonolysis of a 
carbon-carbon double bond at the (14)-position on the 
sphingoid backbone (15) (see supplementary Fig. 1A and 
supplementary Table 1). Conversely, in the OzID spectra 
obtained at a CV of 20 V (Fig. 3C), these product ions were 
absent, while fragments arising from oxidative cleavage of 
a (4)-double bond (neutral losses of 180 and 164) were 
observed at m/z 104 and 120 for  the unlabeled standard 
(see supplementary Fig. 1B and supplementary Table 1). 
Of this pair of ions, the aldehyde is mass-shifted and ap-
pears, as expected, at m/z  107  for  the  D3-isotopologue, 
while the m/z 123 is absent in this spectrum, possibly due 
to the lower abundance of the CV = 20 V feature in the na-
tive extract. Interestingly, an abundant water loss was ob-
served in the spectra in Fig. 3C, which is much diminished 
in the spectra in Fig. 3B, providing further evidence of the 
structural difference between the two lipids.
DMS-OzID  analysis  was  also  performed  on  nonhydro-
lyzed lipid extract from HEK cells. Four 1-deoxyceramide 
species could be detected as [M+H]+ ions, consistent 
with the assignments: Cer m18:1/16:0, Cer m18:1/18:0, 
Cer m18:1/22:0, and Cer m18:1/24:1. As before, the OzID 
spectra showed a neutral loss of 40 Da as a characteristic 
signature for 1-deoxySO with a carbon-carbon double 
bond at the (14)-position  (Fig. 4). These data support 
the presence of the (14) carbon-carbon double bond in 
both 1-deoxyceramide and the 1-deoxySO and exclude 
the possibility that the observed (14) desaturation  is 
formed as an artifact of the hydrolysis reaction.
Synthesis of deoxySO standards
Although the previous analysis confirmed the (14) 
carbon-carbon double bond in native 1-deoxySO, it did 
not unambiguously assign the stereochemistry of the 
bond. To further confirm the position and configuration 
of the double bond, a number of 1-deoxySO analogs with 
different  double  bond  positions  and  confirmations  (5E, 
from DMDS adduct of native 1-deoxySO (m/z of 378.2857) was in excellent agreement (<1 ppm) with the 
calculated m/z of 378.2859 (C20H44NOS2
+). The precursor ion was selected for CID yielding to the spectrum 
shown. Product ions A (m/z 274) and B (m/z 103) are indicated in the spectrum and are diagnostic for a 
fragmentation at (14) position. B:  Spectrum  from SPH m18:1(4E)(3OH)  showing product  ion B  (m/z 
243). C: Spectrum from SPH m18:1(14Z)(3OH) showing product ions A (m/z 274) and B (m/z 103). Putative 
structures for the diagnostic product ions are shown as insets in the spectra.
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Fig. 3.  ESI(+) was undertaken on a mixture of D3-labeled hydrolyzed HEK cell lipid extracts spiked with unlabeled synthetic standards, SPH 
m18:1(4E)(3OH) and SPH m18:1(14E)(3OH). A: Ionograms showing separation in voltage space of the [M+H]+ ions formed from the two 
lipid isomers. Each of the synthetic lipids spiked into the extract produced a peak in the black trace (m/z 284) and similar features were ob-
served for the labeled HEK293 extract shown in the red trace (m/z 287). B: OzID spectra obtained for synthetic standard (black spectrum) and 
the D3-labeled extract (red spectrum) corresponding to the first feature in the ionogram (i.e., CV = 17 V ozone reaction time of 100 ms). C: 
OzID spectra obtained for synthetic standard (black spectrum) and the D3-labeled extract (red spectrum) corresponding to the second feature 
in the ionogram (i.e., CV = 20 V ozone reaction time of 15 s). OzID product ions characteristic of the locations of the carbon-carbon double 
bonds are indicated by closed circles and enable assignment of the position of unsaturation to (14)-position (B) and (4)-position (C).
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Elucidating the chemical structure of native 1-deoxySO 1201
From these results, we conclude that native 1-deoxySO 
bears a (14Z) double bond.
DISCUSSION
The 1-deoxySO is an atypical sphingolipid that lacks the 
1-hydroxyl group of canonical sphingosine. It is a down-
stream metabolite of 1-deoxySA, which is formed by SPT 
due to its alternative activity with alanine. Because of the 
missing C1-hydroxyl group, 1-deoxySO cannot be phos-
phorylated to S1P and, therefore, also cannot be degraded 
by S1P-lyase (2).
Pathologically elevated 1-deoxySLs play an important 
role in the inherited neuropathy HSAN I but were also 
found in other conditions, like the metabolic syndrome 
and type 2 diabetes (3, 7). However, the metabolism of 
1-deoxySLs and their molecular structures have not been 
investigated in detail yet. Comparing native 1-deoxySO to 
Fig. 4.  ESI(+)-OzID spectra obtained for m/z values 
corresponding to deoxyceramides present in an non-
hydrolyzed HEK cell lipid extract. All spectra show a 
product ion at m/z 266, which is consistent with the 
collision-induced dehydration of the backbone fol-
lowed by cleavage of the amide bond to liberate the 
acyl chain. Product ions arising from a characteristic 
neutral  loss  of  40  Da  from  the  [M+H]+ or [M+H-
H2O]
+ are marked with circles and are consistent with 
an n-4 double bond (i.e., a 14 double bond in the 
SPH m18:1 backbone). Product ions arising from a 
characteristic neutral loss of 110 Da from the [M+H]+ 
or [M+H-H2O]
+ are marked with squares and are con-
sistent with the presence of an n-9 double bond (e.g., 
24:1  15 acyl chain). These spectra are consistent 
with the deoxyceramides Cer m18:1(14)/16:0 (A), 
Cer m18:1(14)/18:0  (B),  Cer  m18:1(14)/22:0 
(C), and Cer m18:1(14)/24:1(15)  (D)  (see  also 
supplementary Fig. 2 and supplementary Table 1). 
Product ions marked with an asterisk (*) showed dif-
ferent mobility characteristics to the OzID peaks and 
likely arise from isobaric interference.
Retention-time correlation of native lipids with synthetic 
standards
The RPLC retention times of the synthetic SPH m18:1(E)
(3OH) standards with double bonds in positions 5E, 
8E, 12E,  and14E were compared. We observed an in-
verse logarithmic correlation (R2 = 0.96) between reten-
tion times and the double bond position (Fig. 5A). The 
more  the  double  bond  (DB)  was  positioned  toward  
the omega end, the earlier the molecule eluted from 
the column. The closest match in retention time between 
native 1-deoxySO and the synthetic standards was seen 
again  for SPH m18:1(14E)(3OH), although the elution 
time between the two compounds still differed by about 
30 s (Fig. 5B).
To further elucidate the DB configuration, we compared 
the retention times of native 1-deoxySO with the synthetic 
standard in (14Z) configuration (Fig. 5B, supplementary 
Fig. 3). The SPH m18:1(14Z) eluted at 13.0 min and there-
fore coincided with the elution time of native 1-deoxySO. 
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1-deoxySO bears  a  (14Z)  instead of  a  (4E) DB  indicates 
that the metabolism of 1-deoxySL deviates from that of ca-
nonical sphingolipids. Interestingly, sphingadiene, a poly-
unsaturated downstream product of sphingosine (17), has 
double bonds at both the (4E) and (14Z) positions (Fig. 
5C). The presence of a (14Z) double bond in both sphin-
gadiene and native 1-deoxySO suggests that both metabo-
lites are substrates of the same desaturase, although the 
responsible enzyme is unknown so far (18). The fact that 
exogenously added D3-lableled 1-deoxySA is converted to 
D3-labeled 1-deoxySO also showed that the double bond is 
introduced downstream of 1-deoxySA and not formed by an 
SPT-mediated incorporation of an unsaturated acyl-CoA. 
Interestingly, 1-deoxymethylsphingosine, the correspond-
ing downstream product of 1-deoxymethylsphinganine, 
Scheme 1.  Synthesis of the 14Z-deoxySO analog. Reagents and conditions: DHP, p-toluenesulfonic acid (cat.), THF:DCM, 0°C-rt, 12 h 
(a); CBr4, PPh3, DCM, 0°C-rt, 4 h (b); i) 1-pentyne, tert-BuLi, toluene, 78°C, 1 h, and then ii) DMPU, 4, THF, 78°C-rt, 7 h (c); H2, EDA, 
Lindlar catalyst, 5% DMF in EtOAc, 0°C, 6 h (d); PPTS (cat.), ethanol, 62°C, 2 h (e); i) Mg, 1,2-DBE (drops), Et2O, reflux, 2 h, and then 
ii) 2, MeMgBr, DCM:Et2O, reflux, 2 h (f); tri-(tert-butoxy)-aluminum hydride, ethanol, 78°C, 1 h (g); 4 M HCl-dioxane, 0°C, 3 h (h).
Fig. 5. A: RPLC retention times (RT) for a set of 
synthetic SPH m18:1 standards having double bonds 
in positions (4E), (5E), (8E), (12E), and (14E). The 
position of the double bond within the alkyl chain 
showed a logarithmic correlation to the retention 
times. B: Comparing the retention times of native 
1-deoxySO to the synthetic standards, SPH m18:1 
(14Z) and SPH m18:1 (14E),  identified native 1-de-
oxySO as SPH m18:1 (14Z) (****P < 0.0001). C: Com-
parison of the chemical structures of 1-deoxySO and 
sphingadiene.
a synthetic SPH m18:1(4E) standard by RPLC, we observed 
a significant deviation in retention time, although the m/z 
was identical for both molecules. Analyzing the DMDS de-
rivatized adducts of native 1-deoxySO by MS2 revealed two 
specific fragments, which indicated the double bond posi-
tion at (14) and, therefore, distinct to that of the canonical 
(4)-position. The (14)-position was further confirmed 
using differential-mobility spectrometry combined with OzID. 
Comparing retention times of native 1-deoxySO to a set of 
synthetic SPH m18:1 standards finally confirmed a (14Z) 
DB in native 1-deoxySO.
During sphingolipid de novo synthesis,  the sphingo-
lipid delta(4)-desaturase 1 normally  introduces  a  (4E) 
double bond into the sphingoid base backbone of dihydro-
ceramide to form ceramide. The observation that native 
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which is formed by the condensation with glycine, seems 
to contain a (3E) DB. The m/z as well as RPLC retention 
time of native 1-deoxymethylsphingosine matched that of 
a synthetic m17:1 (3E)(2OH) standard (supplementary 
Fig. 4). As 1-deoxymethylsphingosine contains only 17 
carbons,  this equals  the (4E) DB position of canonical 
sphingolipids.
In conclusion we provide strong evidence from multiple 
orthogonal analytical techniques to unambiguously assign 
native 1-deoxySO as it is formed in HEK293 cells to be a 
SPH m18:1(14Z)(3OH) structure. This furthermore im-
plies that 1-deoxyceramides are metabolized distinct from 
canonical sphingolipids. However, more detailed studies 
are needed to further investigate the enzymatic pathways 
and metabolic steps involved in the conversion of these 
lipids.
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